ASP7962 + Placebo
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety
Conditions
Safety, Tolerability, Pharmacokinetics of ASP7962
Trial Timeline
Nov 1, 2013 → May 1, 2014
NCT ID
NCT01981928About ASP7962 + Placebo
ASP7962 + Placebo is a phase 1 stage product being developed by Astellas Pharma for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT01981928. Target conditions include Safety, Tolerability, Pharmacokinetics of ASP7962.
What happened to similar drugs?
3 of 4 similar drugs in Safety were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02136316 | Phase 1 | Completed |
| NCT01981928 | Phase 1 | Completed |
Competing Products
20 competing products in Safety